Stock Price Quote

SWET-CHEM ANTIBIOTICS LTD.

NSE : NABSE : 531186ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
- Chairman - Managing Director
Registered Office

Address B -37, Ug - 3, Madhu Vihar Market,Patparganj, ,
Delhi,
Delhi-110092

Phone

Email sukhdevsingh51@hotmail.com

Website  

Registrars Details
Not Available
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  15666.65 (9.86%)
M.Cap ( in Cr)20100.14
Abbott India (BSE)
peergroup  29032.70 (0.67%)
M.Cap ( in Cr)61692.46
RPG Life Sciences (BSE)
peergroup  2829.70 (5.32%)
M.Cap ( in Cr)4680.05
SMS Lifesciences (BSE)
peergroup  1638.35 (5.00%)
M.Cap ( in Cr)495.32
Jubilant Pharmova (BSE)
peergroup  1221.50 (6.21%)
M.Cap ( in Cr)19456.19

Shareholding Pattern

PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
NON-INSTITUTION 0%

About Swet-Chem Antibiotics Ltd.

Swet-Chem Antibiotics Ltd. was incorporated in the year 1992. Its today's share price is 0. Its current market capitalisation stands at Rs 0 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Neksey Lal, Anil Kumar Shrivastava, Sukhdev Singh.

It is listed on the BSE with a BSE Code of 531186 , NSE with an NSE Symbol of and ISIN of . It's Registered office is at B -37, Ug - 3, Madhu Vihar Market,Patparganj, Delhi-110092, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are YP Singhal & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.